European Medical Alliance

References

1. Barbaro B, Schulsinger A, Valentini V et al (1999) The accuracy of transrectal ultrasound in predicting the pathological stage of low-lying rectal cancer after pre-operative chemoradiation therapy. Int J Radiat Oncol Biol Phys 43:1043-1047

2. Jass JR, Love SB, Northover JM (1987) A new prognostic classification of rectal cancer. Lancet 1:1303-1306

3. Greene FL, Page DL, Fleming ID et al (eds) (2002) AJCC Cancer Staging Manual, 6th Edn. Springer Berlin Heidelberg New York

4. Morson BC, Whiteway JE, Jones EA et al (1984) Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut 25:437-444

5. Breivik J, Gaudernack G (1999) Carcinogenesis and natural selection: a new perspective to the genetics and epigenetics of colorectal cancer. Adv Cancer Res 76:187-212

6. Gryfe R, Swallow C, Bapat B et al (1997) Molecular biology of colorectal cancer. Curr Probl Cancer 21:233-300

7. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159-170

8. Konishi M, Kikuchi-Yanoshita R, Tanaka K et al (1996) Molecular nature of colon tumours in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111:307-317

9. Jen J, Kim H, Piantadosi S et al (1994) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331:213-221

10. Prolla TA, Baker SM, Harris AC et al (1998) Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet 18:276-279

11. Jiricny J (1998) Replication errors: cha(lle)nging the genome. EMBO J 17:6427-6436

12. Kane MF, Loda M, Gaida GM et al (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumours and mismatch repair-defective human tumor cell lines. Cancer Res 57:808-811

13. Herman JG, Graff JR, Myohanen S et al (1996) Methyl-

ation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826

14. Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorec-tal cancer. Cancer Res 58:5248-5257

15. Horii A, Han HJ, Shimada M et al (1994) Frequent replication errors at microsatellite loci in tumours of patients with multiple primary cancers. Cancer Res 54:3373-3375

16. Herman JG, Umar A, Polyak K et al (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95:6870-6875

17. Ohno S, Tomoda M, Tomisaki S et al (1997). Improved surgical results after combining preoperative hyperthermia with chemotherapy and radiotherapy for patients with carcinoma of the rectum. Dis Colon Rectum 40:401-406

18. Stein U, Rau B, Wust P et al (1999) Hyperthermia for treatment of rectal cancer: evaluation for induction of multidrug resistance gene (mdr1) expression. Int J Cancer 80:5-12

19. Wheeler JM, Warren BF, Jones AC et al (1999) Preoperative radiotherapy for rectal cancer: implications for surgeons, pathologists and radiologists. Br J Surg 86:1108-1120

20. Hobday TJ, Erlichman C (2001) Colorectal cancer. In: Gospodarowicz MK, Henson DE, Hutter RVP et al (eds) Prognostic factor in cancer. Wiley-Liss, New York, pp 333-347

21. Bull AD, Biffin AH, Mella J et al (1997) Colorectal cancer pathology reporting: a regional audit. J Clin Pathol 50:138-142

22. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP (2000) American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 88:1739-1757

23. Zamboni G, Lanza G, Risio M (1999) Colorectal adenoma-carcinoma. Guidelines and minimal diagnostic criteria. Italian Group for Pathology of the Digestive System. Pathologica 91:286-294

24. Hamilton SR, Aaltonen LA (eds) (2000) World Health Organization Classification of Tumours: pathology and genetics of tumours of the digestive system. IARCP Press, Lyon

25. Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979-994

26. Compton CC (1999) Pathology report in colon cancer: what is prognostically important? Dig Dis 17:67-79

27. Smyrk TC (1994) Colon cancer connections. Cancer syndrome meets molecular biology meets histopathol-ogy. Am J Pathol 145:1-6

28. Kim H, Jen J, Vogelstein B, Hamilton SR (1994) Clinical and pathological characteristics of sporadic col-orectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 145:148-156

29. Jass JR, Smyrk TC, Stewart SM et al (1994) Pathology of hereditary non polyposis colon cancer. Anticancer Res 14:1631-1634

30. Sasaki S, Masaki T, Umetani N et al (1998) Characteristics in primary signet-ring cell carcinoma of the col-orectum, from clinicopathological observations. Jpn J Clin Oncol 28:202-206

31. Riddel RH, Petras RE, Williams GT, Sabin LH (2002) Tumors of the intestines. In: Rosai J, Sobin LH (eds) Atlas of tumor pathology. Armed Forces Institute of Pathology, Washington DC, fascicle 32

32. Hermanek P, Guggenmoos-Holzmann I, Gall FP (1989) Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification. Dis Colon Rectum 32:593-599

33. Wittekind C, Henson DE, Hutter RVP, Sobin LH (eds) (2001) TNM supplement. A commentary of uniform use, 2nd Edn. Wiley-Liss, New York

34. Shepherd NA, Baxter KJ, Love SB (1997) The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 112:1096-1102

35. Chapuis PH, Dent OF, Fisher R et al (1985) A multi-variate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 72:698-702

36. Talbot IC, Ritchie S, Leighton M et al (1981) Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology 5:141-163

37. Talbot IC, Ritchie S, Leighton MH et al (1980) The clinical significance of invasion of veins by rectal cancer. Br J Surg 67:439-442

38. Volk EE, Goldblum JR, Petras RE et al (1995) Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology 109:1801-1807

39. Michelassi F, Block GE, Vannucci L et al (1988) A 5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma. Ann Surg 208:379-389

40. Knudsen JB, Nilsson T, Sprechler M et al (1983) Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum. Dis Colon Rectum 26:613-617

41. Jass JR, Atkin WS, Cuzick J et al (1986) The grading of rectal cancer: historical perspectives and a multivari-ate analysis of 447 cases. Histopathology 10:437-459

42. Carlon CA, Fabris G, Arslan-Pagnini C et al (1985) Prognostic correlations of operable carcinoma of the rectum. Dis Colon Rectum 28:47-50

43. Ono M, Sakamoto M, Ino Y et al (1996) Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Cancer 78:1179-1186

44. Deans GT, Heatley M, Anderson N et al (1994) Jass' classification revisited. J Am Coll Surg 179:11-17

45. Jass JR, Ajioka Y, Allen JP et al (1996) Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 28:543-548

46. Morodomi T, Isomoto H, Shirouzu K et al (1989) An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 63:539-543

47. Hase K, Shatney C, Johnson D et al (1993) Prognostic value of tumor "budding" inpatients with colorectal cancer. Dis Colon Rectum 36:627-635

48. Ueno H, Murphy J, Jass JR et al (2002) Tumor "budding" as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127-132

49. Graham DM, Appelman HD (1990) Crohn's-like lym-phoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol 3:332-335

50. Harrison JC, Dean PJ, el-Zeky F et al (1995) Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis. Hum Pathol 26:31-38

51. Birbeck KF, Macklin CP, Tiffin NJ et al (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235:449-457

52. Wibe A, Rendedal PR, Svensson E et al (2002) Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89:327-334

53. Nagtegaal ID, van de Velde CJ, van der Worp E et al (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729-1734

54. Adam IJ, Mohamdee MO, Martin IG et al (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344:707-711

55. Chan KW, Boey J, Wong SK (1985) A method of reporting radial invasion and surgical clearance of rectal carcinoma. Histopathology 9:1319-1327

56. Quirke P, Durdey P, Dixon MF et al (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2: 996-999

57. Arbman G, Nilsson E, Hallbook O et al (1996) Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 83:375-379

58. Heald RJ, Karanjia ND (1992) Results of radical surgery for rectal cancer. World J Surg 16:848-857

59. MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341:457-460

60. Enker WE, Thaler HT, Cranor ML et al (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335-346

61. Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646

62. Compton CC, Greene FL (2004) The staging of col-orectal cancer: 2004 and beyond. CA Cancer J Clin 54:295-308

63. Goldstein NS (2002) Lymph nodes recoveries from 2427 pT3colorectal resection specimens spanning 45 years. Recommendations for a minimum number of recovered of lymph nodes based on predictive probabilities. Am J Surg Pathol 26:179-189

64. Cserni G (2003) Nodal staging of colorectal carcinomas and sentinel nodes. J Clin Pathol 56:327-335

65. Colacchio TA, Forde KA, Scantlebury VP (1981) Endo scopic polypectomy: inadequate treatment for invasive colorectal carcinoma. Ann Surg 194:704-707

66. Lipper S, Kahn LB, Ackerman LV (1983) The significance of microscopic invasive cancer in endoscopical-ly removed polyps of the large bowel. A clinicopatho-logic study of 51 cases. Cancer 52:1691-1699

67. Cooper HS (1983) Surgical pathology of endoscopical-ly removed malignant polyps of the colon and rectum. Am J Surg Pathol 7:613-623

68. Haggitt RC, Glotzbach RE, Soffer EE et al (1985) Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 89:328-336

69. Cranley JP, Petras RE, Carey WD et al (1986) When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology 91:419-427

70. Wilcox GM, Anderson PB, Colacchio TA (1986) Early invasive carcinoma in colonic polyps. A review of the literature with emphasis on the assessment of the risk of metastasis. Cancer 57:160-171

71. Christie JP (1988) Polypectomy or colectomy? Management of 106 consecutively encountered colorectal polyps. Am Surg 54:93-99

72. Wilcox GM, Beck JR (1987) Early invasive cancer in adenomatous colonic polyps ("malignant polyps"). Evaluation of the therapeutic options by decision analysis. Gastroenterology 92:1159-1168

73. Richards WO, Webb WA, Morris SJ et al (1987) Patient management after endoscopic removal of the cancerous colon adenoma. Ann Surg 205:665-672

74. Cooper HS (1988) The role of the pathologist in the management of patients with endoscopically removed malignant colorectal polyps. Pathol Annu 23:25-43

75. Coverlizza S, Risio M, Ferrari A et al (1989) Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential. Cancer 64:1937-1947

76. Muller S, Chesner IM, Egan MJ et al (1989) Significance of venous and lymphatic invasion in malignant polyps of the colon and rectum. Gut 30:1385-1391

77. Geraghty JM, Williams CB, Talbot IC (1991) Malignant colorectal polyps: venous invasion and successful treatment by endoscopic polypectomy. Gut 32: 774-778

78. Nivatvongs S, Rojanasakul A, Reiman HM et al (1991) The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma. Dis Colon Rectum 34:323-328

79. Kyzer S, Begin LR, Gordon PH et al (1992) The care of patients with colorectal polyps that contain invasive adenocarcinoma. Endoscopic polypectomy or colecto-my? Cancer 70:2044-2050

80. Cooper HS, Deppisch LM, Gourley WK et al (1995) Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology 108:1657-1665

81. Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Risk factors for an adverse outcome in early invasive col-orectal carcinoma. Gastroenterology 127:385-394

82. Ueno H, Mochizuki H, Shinto E et al (2002) Histologic indices in biopsy specimens for estimating the probability of extended local spread in patients with rectal carcinoma. Cancer 94:2882-2891

83. Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer. Ann Surg 239:34-42

84. Bouzourene H, Bosman FT, Seelentag W et al (2002) Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 94:1121-1130

85. Wheeler JM, Warren BF, Mortensen NJ et al (2002) Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system. Dis Colon Rectum 45:1051-1056

86. Kaminsky-Forrett MC, Conroy T, Luporsi E et al (1998) Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 42:935-941

87. Bozzetti F, Baratti D, Andreola S et al (1999) Preoper-ative radiation therapy for patients with T2-T3 carcinoma of the middle-to-lower rectum. Cancer 86:398-404

88. Janjan NA, Khoo VS, Abbruzzese J et al (1999) Tumor downstaging and sphincter preservation with preoper-ative chemoradiation in locally advanced rectal cancer: the M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 44:1027-1038

89. Mandard AM, Dalibard F, Mandard JC et al (1994) Pathologic assessment of tumor regression after preop-erative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73:2680-2686

90. Shia J, Guillem JG, Moore HG et al (2004) Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 28:215-223

91. Chung DC (1998) Molecular prognostic markers and colorectal cancer: the search goes on. Gastroenterology 114:1330-1332

92. McLeod HL, Murray GI (1999) Tumour markers of prognosis in colorectal cancer. Br J Cancer 79:191-203

93. Halling KC, French AJ, McDonnell SK et al (1999) Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 91:1295-1303

94. Wright CM, Dent OF, Barker M et al (2000) Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer. Br J Surg 87:1197-1202

95. O'Connor PM, Jackman J, Bae I et al (1997) Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res 57:4285-4300

96. Aebi S, Kurdi-Haidar B, Gordon R et al (1996) Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 56:3087-3090

97. Fink D, Nebel S, Aebi S et al (1996) The role of DNA mismatch repair in platinum drug resistance. Cancer Res 56:4881-4886

98. Davis TW, Wilson-Van Patten C, Meyers M et al (1998) Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res 58:767-778

99. Lukish A (1998) Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann Surg 227:51-56

100. Fu CG, Tominaga O, Nagawa H et al (1998) Role of p53 and p21/WAF1 detection in patient selection for pre-operative radiotherapy in rectal cancer patients. Dis Colon Rectum 41:68-74

Was this article helpful?

0 0